213 related articles for article (PubMed ID: 36772592)
1. A Two-Step Feature Selection Radiomic Approach to Predict Molecular Outcomes in Breast Cancer.
Brancato V; Brancati N; Esposito G; La Rosa M; Cavaliere C; Allarà C; Romeo V; De Pietro G; Salvatore M; Aiello M; Sangiovanni M
Sensors (Basel); 2023 Jan; 23(3):. PubMed ID: 36772592
[TBL] [Abstract][Full Text] [Related]
2. DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.
Monti S; Aiello M; Incoronato M; Grimaldi AM; Moscarino M; Mirabelli P; Ferbo U; Cavaliere C; Salvatore M
Contrast Media Mol Imaging; 2018; 2018():5076269. PubMed ID: 29581709
[TBL] [Abstract][Full Text] [Related]
3. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
[TBL] [Abstract][Full Text] [Related]
4. Conditional generative adversarial network driven radiomic prediction of mutation status based on magnetic resonance imaging of breast cancer.
Huang ZH; Chen L; Sun Y; Liu Q; Hu P
J Transl Med; 2024 Mar; 22(1):226. PubMed ID: 38429796
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the clinicopathological subtypes of breast cancer using a fisher discriminant analysis model based on radiomic features of diffusion-weighted MRI.
Ni M; Zhou X; Liu J; Yu H; Gao Y; Zhang X; Li Z
BMC Cancer; 2020 Nov; 20(1):1073. PubMed ID: 33167903
[TBL] [Abstract][Full Text] [Related]
6. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
7. Generative adversarial network-based super-resolution of diffusion-weighted imaging: Application to tumour radiomics in breast cancer.
Fan M; Liu Z; Xu M; Wang S; Zeng T; Gao X; Li L
NMR Biomed; 2020 Aug; 33(8):e4345. PubMed ID: 32521567
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
9. Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics.
Fan M; Yuan W; Zhao W; Xu M; Wang S; Gao X; Li L
IEEE J Biomed Health Inform; 2020 Jun; 24(6):1632-1642. PubMed ID: 31794406
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer.
Xu R; You T; Liu C; Lin Q; Guo Q; Zhong G; Liu L; Ouyang Q
Front Oncol; 2023; 13():1216446. PubMed ID: 37583930
[TBL] [Abstract][Full Text] [Related]
11. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.
Ramtohul T; Djerroudi L; Lissavalid E; Nhy C; Redon L; Ikni L; Djelouah M; Journo G; Menet E; Cabel L; Malhaire C; Tardivon A
Radiology; 2023 Aug; 308(2):e222646. PubMed ID: 37526540
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient value measurements with diffusion magnetic resonance imaging correlated with the expression levels of estrogen and progesterone receptor in breast cancer: A meta-analysis.
Meng L; Ma P
J Cancer Res Ther; 2016; 12(1):36-42. PubMed ID: 27072207
[TBL] [Abstract][Full Text] [Related]
15. Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI/DCE-MRI and immunohistochemical tumor markers.
Allarakha A; Gao Y; Jiang H; Wang PJ
Discov Med; 2019 Jan; 27(146):7-15. PubMed ID: 30695671
[TBL] [Abstract][Full Text] [Related]
16. DCE-MRI Radiomics Analysis in Differentiating Luminal A and Luminal B Breast Cancer Molecular Subtypes.
Lafcı O; Celepli P; Seher Öztekin P; Koşar PN
Acad Radiol; 2023 Jan; 30(1):22-29. PubMed ID: 35595629
[TBL] [Abstract][Full Text] [Related]
17. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
Front Oncol; 2021; 11():706733. PubMed ID: 34490107
[TBL] [Abstract][Full Text] [Related]
18. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
19. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
20. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status.
Kayadibi Y; Kocak B; Ucar N; Akan YN; Yildirim E; Bektas S
Acad Radiol; 2022 Jan; 29 Suppl 1():S126-S134. PubMed ID: 34876340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
